Valderrama-Penagos JX, Dueñas-Quintero KL, Guzmán-Ortiz KA

Language: Spanish
References: 19
Page: 212-221
PDF size: 243.61 Kb.

ABSTRACT

Introduction: Obstructive sleep apnea (OSA) is a complex condition with multiple causative factors contributing to poor adherence to positive pressure systems since problems with device and conditions inherent to the patient. This study aims to describe the frequency of such factors reported in the literature for patients treated between 2015-2020. Methods: Observational, descriptive, case series study. The medical history was reviewed, and a survey was completed. Clinical, physical, and device-related variables were characterized and described. Results: 26 patients were analyzed in this study, 76.9% were male and 23.1% female. The average age of the patients was 51.2 ± 13.2 years. The body mass index (BMI) was 27.8, of which only 7 patients had a normal index (‹25; 26.9%). 10 patients at the time of the first consultation do not have daytime sleepiness (38.5%). The apnea hypopnea index (AHI) was on average 37.4/hour ± 17.5. 6 patients with treatment pressure less than or equal to 8 cmH2O (30%) and 14 patients with pressure greater (70%). The residual AHI was on average 8.3 events/hour ± 10.1. Conclusions: The frequency of factors associated with poor treatment adherence underscores the need for comprehensive psychosocial assessments, detailed clinical histories, and thorough physical assessment to identify barriers to adherence and develop effective therapeutic strategies.

REFERENCES

1. Copur AS, Erik Everhart D, Zhang C, Chen Z, Shekhani H,Mathevosian S, et al. Effect of personality traits on adherencewith positive airway pressure therapy in obstructive sleep apneapatients. Sleep Breath. 2018 May;22(2):369-76. doi: 10.1007/s11325-017-1559-5

2. Chen YF, Hang LW, Huang CS, Liang SJ, Chung WS.Polysomnographic predictors of persistent continuous positiveairway pressure adherence in patients with moderate and severeobstructive sleep apnea. Kaohsiung J Med Sci. 2015;31(2):83-9. doi: 10.1016/j.kjms.2014.11.004

3. Akashiba T, Inoue Y, Uchimura N, Ohi M, Kasai T, KawanaF, et al. Sleep Apnea Syndrome (SAS) Clinical PracticeGuidelines 2020. Respir Investig. 2022;60(1):3-32. doi:10.1016/j.resinv.2021.08.010

4. Carrillo Alduenda JL, Arreondo del Bosque FM, Reyes ZúñigaM, Castorena Maldonado A, Vázquez García JC, Torre-Bouscoulet L. Síndrome de apnea obstructiva del sueño enpoblación adulta. Neumol Cir Torax. 2010;69(2):103-15.

5. Luo K, Zhang L, Zhang X, Han T, Li Y, Wang C. Acceptanceof and six-month adherence to continuous positive airwaypressure in patients with moderate to severe obstructive sleepapnea. Clin Respir J. 2021;15(1):56-64. doi: 10.1111/crj.13269

6. Bravata DM. Identifying predictors of adherence to positiveairway pressure: the next step in implementing sleep apneamanagement for patients with cerebrovascular events. SleepMed. 2020;66:241-42. doi: 10.1016/j.sleep.2020.01.005

7. Mehrtash M, Bakker JP, Ayas N. Predictors of ContinuousPositive Airway Pressure Adherence in Patients withObstructive Sleep Apnea. Lung. 2019;197(2):115-21. doi:10.1007/s00408-018-00193-1

8. Picard F, Panagiotidou P, Weinig L, Steffen M, Tammen AB,Klein RM. Effect of CPAP therapy on nocturnal blood pressurefluctuations, nocturnal blood pressure, and arterial stiffness inpatients with coexisting cardiovascular diseases and obstructivesleep apnea. Sleep Breath. 2021;25(1):151-61. doi: 10.1007/s11325-020-02075-4

9. Drager LF, Malhotra A, Yan Y, Pépin JL, Armitstead JP,Woehrle H, et al. Adherence with positive airway pressuretherapy for obstructive sleep apnea in developing vs. developedcountries: a big data study. J Clin Sleep Med. 2021;17(4):703-9. doi: 10.5664/jcsm.9008

10. Engleman HM, Wild MR. Improving CPAP use by patientswith the sleep apnoea/hypopnoea syndrome (SAHS). SleepMed Rev. 2003;7(1):81-99. doi: 10.1053/smrv.2001.0197

11. Catcheside PG. Predictors of continuous positive airwaypressure adherence. F1000 Med Rep. 2010;2:70. doi: 10.3410/M2-70

12. McArdle N, Devereux G, Heidarnejad H, Engleman HM,Mackay TW, Douglas NJ. Long-term use of CPAP therapy forsleep apnea/hypopnea syndrome. Am J Respir Crit Care Med.1999;159(4 Pt 1):1108-14. doi: 10.1164/ajrccm.159.4.9807111

13. Nino-Murcia G, McCann CC, Bliwise DL, GuilleminaultC, Dement WC. Compliance and side effects in sleep apneapatients treated with nasal continuous positive airway pressure.West J Med. 1989;150(2):165-9.

14. Hoffstein V, Viner S, Mateika S, Conway J. Treatment ofobstructive sleep apnea with nasal continuous positive airwaypressure. Patient compliance, perception of benefits, and sideeffects. Am Rev Respir Dis. 1992;145(4 Pt 1):841-5. doi:10.1164/ajrccm/145.4_Pt_1.841

15. Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, RichardsKC, Weaver TE. A systematic review of CPAP adherence acrossage groups: clinical and empiric insights for developing CPAPadherence interventions. Sleep Med Rev. 2011;15(6):343-56.doi: 10.1016/j.smrv.2011.01.003

16. Van Ryswyk E, Anderson CS, Antic NA, Barbe F, Bittencourt L,Freed R, et al. Predictors of long-term adherence to continuouspositive airway pressure in patients with obstructive sleepapnea and cardiovascular disease. Sleep. 2019;42(10):zsz152.doi: 10.1093/sleep/zsz152

17. Zampogna E, Spanevello A, Lucioni AM, Facchetti C, SotgiuG, Saderi L, et al. Adherence to Continuous Positive AirwayPressure in patients with Obstructive Sleep Apnoea. A ten yearreal life study. Respir Med. 2019;150:95-100. doi: 10.1016/j.rmed.2019.02.017

18. Weaver TE. Novel Aspects of CPAP Treatment and Interventionsto Improve CPAP Adherence. J Clin Med. 2019;8(12):2220.doi: 10.3390/jcm8122220

19. Aalaei S, Rezaeitalab F, Tabesh H, Amini M, Afsharisaleh L,Mostafavi SM, et al. Factors Affecting Patients’ Adherence toContinuous Positive Airway Pressure Therapy for ObstructiveSleep Apnea Disorder: A Multi-Method Approach. Iran J MedSci. 2020;45(3):170-78. doi: 10.30476/ijms.2019.45785